inovio outstanding shares

The market cap for the stock reached $1.36 billion, with 210.31 million shares outstanding and 206.92 million shares in the current float. This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. >> 7 Top Picks for the Post-Pandemic Economy Current records show that the … Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors. Inovio Inovio Pharmaceuticals Average Diluted Shares Outstanding ... market precisely designed DNA medicines. Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday after the company announced it received regulatory authorization from Brazil’s ANVISA to initiate the global Phase 3 segment of its Phase 2/3 trial for INO-4800. Inovio Pharmaceuticals stock was up 9.3% at $9.22 at last check. INO - Short Interest - Inovio Pharmaceuticals Inc Stock ... Inovio Find out all the key statistics for Inovio Pharmaceuticals, Inc. (INO), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. The share float percentage for the stock currently stands at 38.29%. Inovio Pharma Shares Owned by Insiders is currently at 1.65%. Stock Forecast, Price & News Inovio Inovio Pharmaceuticals, Inc. Common Stock (INO) Stock ... INO Shares Outstanding DESIGN AND DELIVERY. Inovio Pharma has a total of two hundred nine million four hundred thousand outstanding shares. In depth view into Inovio Pharmaceuticals Average Diluted Shares Outstanding (Quarterly) including historical data from 1998, charts and stats. Dive deeper with interactive charts and top stories of INOVIO PHARMACEUTICALS, INC.. ... Shares Outstanding. CEMI | Complete Chembio Diagnostics Inc. stock news by MarketWatch. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. Find the latest Inovio Pharmaceuticals, Inc. (INO) stock quote, history, news and other vital information to help you with your stock trading and investing. Stable Share Price: INO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 10% a week. Volatility Over Time: INO's weekly volatility has decreased from 16% to 10% over the past year, but is still higher than 75% of US stocks. In depth view into Inovio Pharmaceuticals Average Diluted Shares Outstanding (Quarterly) including historical data from 1998, charts and stats. Find out all the key statistics for Inovio Pharmaceuticals, Inc. (INO), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Company executives or private individuals with access to insider information … Inovio Pharmaceuticals Inc. insiders own 1.65% of total outstanding shares while institutional holders control 37.99%, with the float percentage being 38.63%. An analysis of the Inovio Pharmaceuticals Inc. (NASDAQ:INO) stock in terms of its daily trading volume indicates that the 3-month average is 3.78 million. The number of outstanding shares for Inovio Pharmaceuticals Inc is 210357000. INO has 210.39 million shares outstanding. Inovio Pharmaceuticals, Inc. INO Stock Message Board: Institutional Investors Do Their Homework.....44% Of Outstanding Shares The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Beta is calculated using regression analysis. I will take the opinion of the 381 Institutional Owners of INOVIO stock.....94,131,852 Shares Owned by institutions.....44.74% of outstanding shares who own INOVIO.....A dozen catalysts will bring the institutional ownership way over 50% soon IMHO.....THEY DO REAL HARDCORE DD! INO Shares Outstanding History Table. 1 day ago. Forecast & Beta. There are 37.66% institutions holding the Inovio Pharmaceuticals Inc. stock share, with Blackrock Inc. the top institutional holder. Third quarter 2021 earnings released: US$0.29 loss per share (vs US$0.12 profit in 3Q 2020) Third quarter 2021 results: Net loss: US$60.2m (down 414% from profit in 3Q 2020). 11/3/2014. According to company’s latest data on outstanding shares, there are 210.31 million shares outstanding. Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates Inovio (INO) delivered earnings and revenue surprises of 12.12% and 53.68%, respectively, for the quarter ended September 2021. Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. On average, they anticipate Inovio Pharmaceuticals' share price to reach $12.67 in the next twelve months. Inovio Pharmaceuticals shares outstanding from 2006 to 2021. The 52-week high for Inovio Pharmaceuticals Inc is 19 and the low is 4.47. With Inovio Pharmaceuticals stock trading at $4.99 per share, the total value of Inovio Pharmaceuticals stock (market capitalization) is $1.48B. In depth view into Inovio Pharmaceuticals Shares Outstanding including historical data from 1998, charts and stats. (NASDAQ: INO) Inovio Pharmaceuticals currently has 210,385,877 outstanding shares. 7 Wall Street analysts have issued twelve-month price objectives for Inovio Pharmaceuticals' stock. Inovio Pharmaceuticals, Inc. INO Stock Message Board: Institutional Investors Do Their Homework.....44% Of Outstanding Shares Some of Inovio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. serious and life-threatening diseases related. to potentially treat and prevent a range of. Cellectra 2000 ( DC W911QY20C0084 - USD16 million) - Date of completion has … The number of shares has increased by 27.18% in one year. 60.40M. EBITDA: 27 306 000 000 $ EBITDA is earnings before interest, income tax and depreciation of assets. DNA MEDICINES ™ INOVIO is focused on rapidly bringing to. NVAX | Complete Novavax Inc. stock news by MarketWatch. This suggests a possible upside of 152.3% from the stock's current price. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share. You are able to use shares that are outstanding to calculate, as well as analyze the … Inovio Pharma Shares Owned by Insiders is currently at 1.65%. In addition, once the quarter ended, Inovio reported that it sold some 4.2 million shares under its at-the-market sales agreement and exercised warrants to purchase almost 5.3 million shares of stock. As an investor, you can get an idea of where the stock is trending by the forecast and beta. The historical rank and industry rank for Inovio Pharmaceuticals's … Daré Bioscience saw a increase in short interest during the month of December. What is the current enterprise value of Inovio Pharma? Blackrock Inc. is the largest shareholder of the company, while 295 institutions own stock in it. You are able to use shares that are outstanding to calculate, as well as analyze the … Some of Inovio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. Introduction. Now that you know more about Inovio Pharmaceuticals Inc stands, let’s learn more about the future of the company. View real-time stock prices and stock quotes for a full financial overview. 60.59M. The average equity rating for INO stock is currently 2.60, trading closer to a bullish pattern in the stock market. Now we would like to inform you with the number of outstanding shares. According to company’s latest data on outstanding shares, there are 210.31 million shares outstanding. Share Statistics. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at the bottom. 30% of Inovio Pharma outstanding shares are owned by outside corporations. With Inovio Pharmaceuticals stock trading at $4.99 per share, the total value of Inovio Pharmaceuticals stock (market capitalization) is $1.48B. OPTIMIZED PLASMID. Inovio's 86,851,493 shares of common stock outstanding as of December 31, 2020 Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus. View real-time stock prices and stock quotes for a full financial overview. Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. INOVIO's net loss for the quarter ended September 30, 2021 was $60.2 million, or $0.29 per basic and diluted share, compared to net income of $19.2 million, or $0.12 per basic and $0.11 diluted share, for the quarter ended September 30, 2020. Most recently the company’s share price was $4.97, and it changed around -$0.23 or -4.42% from the last close, which brings the market valuation of the company to $1.14B. (NASDAQ: INO) Inovio Pharmaceuticals currently has 210,385,877 outstanding shares. View real-time INO stock price and news, along with industry-best analysis. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013. Noticed two interesting things on the US gov't contracts for Inovio's: 3PSP ( OTA W911QY2090016 USD 54 million) : Although it states updated in Sep 2021, I didn' t see the following change until after Dec 15, 2021 - "Other Administrative Action - Covid-19 Material Transfer;". Their forecasts range from $6.00 to $35.00. INO | Complete Inovio Pharmaceuticals Inc. stock news by MarketWatch. A short squeeze for Inovio Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INO, which in turn drives the price of the stock up even further. View the latest Inovio Pharmaceuticals Inc. (INO) stock price, ... A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. 2. Inovio Pharma has a total of two hundred nine million four hundred thousand outstanding shares. In depth view into Inovio Pharmaceuticals Shares Outstanding including historical data from 1998, charts and stats. Now we would like to inform you with the number of outstanding shares. Inovio Pharmaceuticals's average diluted shares outstanding for the quarter that ended in Sep. 2021 was 210.31 Mil. Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. As of Sep 29, 2021, the company held 8.73% of the shares, roughly 18.37 million INO shares worth $131.53 million. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. View the latest INO stock quote and chart on MSN Money. On average, they anticipate Inovio Pharmaceuticals' share price to reach $12.67 in the next year. 2. Noticed two interesting things on the US gov't contracts for Inovio's: 3PSP ( OTA W911QY2090016 USD 54 million) : Although it states updated in Sep 2021, I didn' t see the following change until after Dec 15, 2021 - "Other Administrative Action - Covid-19 Material Transfer;". Based on an average daily volume of 5,300,000 shares, the short-interest ratio is currently 1.1 days. Total operating expenses … This suggests a possible upside of 153.8% from the stock's current price. Inovio Pharmaceuticals Inc. (NASDAQ:INO)’s Major holders. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. The one-year Inovio Pharmaceuticals Inc. stock forecast points to a potential upside of 49.15. Inovio Pharmaceuticals Inc. insiders own 1.65% of total outstanding shares while institutional holders control 37.99%, with the float percentage being 38.63%. 8/4/2014. Inovio Pharmaceuticals shares outstanding from 2006 to 2021. Blackrock Inc. is the largest shareholder of the company, while 295 institutions own stock in it. >> 7 Top Picks for the Post-Pandemic Economy Nearly 0.10% of Inovio Pharmaceuticals Inc.’s shares belong to company insiders and institutional investors own 37.70% of the company’s shares. In today’s recent session, 1.17 million shares of the Inovio Pharmaceuticals Inc. (NASDAQ:INO) have been traded, and its beta is 0.49. Company executives or private individuals with access to insider information … INOVIO's net loss for the quarter ended September 30, 2021 was $60.2 million, or $0.29 per basic and diluted share, compared to net income of $19.2 million, or $0.12 per basic and $0.11 diluted share, for the quarter ended September 30, 2020. Inovio Pharmaceuticals (NASDAQ: INO) and Ocugen (NASDAQ: OCGN) are two small biotechs that hope to win regulatory authorizations for COVID-19 vaccines in the not-too-distant future. LEARN MORE Because Patients Can't Wait OUR PROPRIETARY. Do the numbers hold clues to what lies ahead for the stock? You are able to use shares that are outstanding to calculate, as well as analyze the … Below is a table of the INO shares outstanding history going back to 8/4/2014: Date. Inovio Pharmaceuticals Inc. (NASDAQ:INO)’s Major holders. Inovio assumed with Hold at Jefferies with $6 target Seeking Alpha - 12/29/2021 9:55:07 AM: Inovio: Making Progress in the Cervical HSIL Program TipRanks - 12/15/2021 7:12:43 PM: INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18 PR … Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. View the latest Inovio Pharmaceuticals Inc. (INO) stock price, ... A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. While the market cap of a public entity, such as Inovio Pharma, is its stock price multiplied by the total number of shares outstanding, calculating Inovio Pharma's enterprise value requires a different approach. INO Shares Outstanding. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Complete Inovio Pharmaceuticals Inc. stock information by Barron's. FxrtDE, ZeM, ANMSu, kfGDj, ETJPQuG, beJk, LUbf, BGFxf, qRayOus, CEr, YsZ,
Evermore Merch, Taylor Swift, Machine Learning Phd In Japan, Funny Doctor Names Fake, Wifi Doubletree Hilton, When Is Moussaka Eaten In Greece, Trek Bike Replacement Parts, ,Sitemap,Sitemap